Abstract:Pulmonary arterial hypertension (PAH) is a life‐threatening lung disease which is characterized by pulmonary vascular remodeling due to the abnormal proliferation of vascular smooth muscle cell (SMCs) and overproduction of extracellular matrix (ECM) proteins including collagen. It has been shown that a number of growth factors such as platelet‐derived growth factor (PDGF) as well as the metabolic shift in energy production from oxidative phosphorylation to glycolysis participate in PAH in animal models and patients. We recently reported that calpain mediates collagen synthesis and proliferation of pulmonary arterial SMCs (PASMCs) contributing to the pathogenesis of PAH. The aim of this study is to investigate the mechanisms by which glycolytic shift induces calpain activation in PAH. PASMCs were incubated with PDGF‐BB (10 ng/ml) for 24 h, after which protein content of 6‐Phosphofructo‐2‐kinase/fructose‐2, 6‐bisphosphatase 3 (PFKFB3) and lactate concentration in the cell lysates and in the culture medium were measured. We found that PDGF‐BB significantly increases the protein levels of PFKFB3 and the lactate production. Our results also showed that inhibition of PFKFB3 attenuates PDGF‐induced calpain activity, collagen synthesis and proliferation of PASMCs. Treatment of PASMCs with lactate markedly increased the activities of calpain and extracellular signal–regulated kinase (ERK) without affecting the protein levels of calpain‐1, calpain‐2 and calpastatin in PASMCs suggesting that it may regulate the calpain activity via posttranslational mechanism. Moreover, inhibition of calpain‐2, but not calpain‐1, attenuates the lactate‐induced collagen synthesis and proliferation of PASMCs. In addition, pre‐treatment of the PASMCs with ERK 1/2 inhibitor PD98059 diminishes increases in calpain‐2 phosphorylation at serine 50, collagen synthesis and proliferation of PASMCs induced by lactate. More importantly, pharmacological inhibition of ERK 1/2 by PD98059 attenuates the progression of Sugen/Hypoxia‐induced pulmonary hypertension and pulmonary vascular remodeling in rats. In summary, we have demonstrated that ERK‐stimulated calpain signaling is a critical pathway in PAH which mediates cell proliferation and collagen synthesis in pulmonary vascular smooth muscle cells via enhanced glycolysis. Support or Funding Information Supported by NIH (YS), Department of Veterans Affairs (YS), FAMRI (YS) and AHA (LK). This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

ERK/Drp1‐dependent mitochondrial fission contributes to HMGB1‐induced autophagy in pulmonary arterial hypertension

Internet Technology: Resources for Perinatal Nurses

Inhibitors of Mitochondrial Dynamics Mediated by Dynamin-Related Protein 1 in Pulmonary Arterial Hypertension

Abstract 15702: Role of the Drp-1 Receptors Mid49 and Mid51 in Regulating Fission and Cell Proliferation in Pulmonary Arterial Hypertension

Abstract 15168: The Role of Mitochondrial Fission Factor (MFF) and Increased Midzone Mitochondrial Fission in Pulmonary Arterial Hypertension: Implications for Proliferation, Mitophagy, and Apoptosis

MFN2-dependent mitochondrial dysfunction contributes to Relm-β-induced pulmonary arterial hypertension via USP18/Twist1/miR-214 pathway

PARM1 Drives Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension via AKT/FOXO3A Axis

HMGB1-induced activation of ER stress contributes to pulmonary artery hypertension in vitro and in vivo

Hypoxia Promotes Pulmonary Vascular Remodeling Via HIF-1α to Regulate Mitochondrial Dynamics

Reactive Oxygen Species Effect PASMCs Apoptosis Via Regulation of Dynamin-Related Protein 1 in Hypoxic Pulmonary Hypertension

MFN2-dependent Mitochondrial Dysfunction Contributes to Relm-(3-induced Pulmonary Arterial Hypertension Via USP18/Twist1/miR-214 Pathway

The HIF-1 alpha/miR-26a-5p/PFKFB3/ULK1/2 axis regulates vascular remodeling in hypoxia-induced pulmonary hypertension by modulation of autophagy

Abstract 12004: Mitochondrial Fission Mediator MiD49 Regulates Proliferation via MYO1C in Pulmonary Arterial Hypertension

Increased Glycolysis Contributes to Pulmonary Vascular Remodeling via ERK-dependent Calpain Activation in Pulmonary Arterial Hypertension

Abstract 108: Mediator 1 Regulation of the BMP / TGF-β Signaling in Endothelium: Implications for Pulmonary Hypertension

Hypoxia Induces Pulmonary Artery Smooth Muscle Dysfunction Through Mitochondrial Fragmentation-Mediated Endoplasmic Reticulum Stress.

Expression of Peptide Fragments from Proadm and Involvement of Mitogen-Activated Protein Kinase Signaling Pathways in Pulmonary Remodeling Induced by High Pulmonary Blood Flow

MED1 Regulates BMP/TGF- in Endothelium: Implication for Pulmonary Hypertension

Role of Dynamin 2 in mitochondrial fission and cell cycle regulation: Dysregulation of a miR-124-3p-STAT3-DNM2-Drp1-RGCC pathway connects fission and cell proliferation in pulmonary arterial hypertension

MED1 Regulates BMP/TGF-β in Endothelium: Implication for Pulmonary Hypertension

Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension